PR85497

VEVEY, Switzerland, September 10, 2020, /PRNewswire=KYODO JBN/--

AlpVision SA, a global leader in advanced signal processing applications, just

announced at the 2020-Intelligent Health Summit that the online access to the

real-time electrical activity of living neurons is now available on BioServer.net

(https://bioserver.net/live ), AlpVision proprietary platform.

As announced by AlpVision's CEO, Dr. Fred Jordan and AlpVision's President,

Dr. Martin Kutter, BioServer.net aims to facilitate the research on advanced

software algorithms using living neurons, by making it possible to perform them

without the direct access to expensive lab facility. This brings a unique

opportunity for worldwide experimental research on software and neuronal

signaling applications to anyone interested in the subject. Access to

Bioserver.net also opens the way for development of low-energy consumption

advanced computing units, made of real neural networks as opposed to the

silicon-based artificial neural networks.

BioServer.net was created by integrating living neuronal cell cultures,

electrical hardware, signal processing tools and internet frontend

technologies. The neurons are obtained by a differentiation of human Induced

Pluripotent Stem Cells. Differentiated neuronal cells are grouped together in

order to form a spheroid shape built of 100'000 to 1'000'000 neurons and of

about 500 micrometers of diameter. Electrodes are used to enable bidirectional

communication between the living neurons and artificial hardware. The ultimate

goal of these neuron-based Biological Neural Networks is to achieve

sophisticated tasks that are impossible using traditional silicon-based

methods, for example the current deep learning algorithms.

This initiative is at the intersection of neuroscience, computer science and

hardware design. It shares some similarities with the NeuralLink project

undertaken by Elon Musk. Both projects share a similar ambition of combining

biological power with hardware in order to open new possibilities. However,

BioServer.net focuses specifically on in vitro cultures. The ultimate objective

of the project is to achieve specific technical functions, such as building tools

with superior computation capabilities and to provide low energy data computation.

The next steps in the BioServer.net development is to implement an API for

programmers to enable direct performance of read/write operations remotely from

their source code and potentially integrate those function calls with standard

TensorFlow/PyTorch operations.

Bioserver.net

Fred Jordan

avinfo-20@alpvision.com

+41 21 948 64 64

Rue du Clos 12, 1800, Vevey, Switzerland

Logo - https://mma.prnewswire.com/media/1251464/AlpVision_Logo.jpg 

SOURCE: BioServer.net